NKTR
Nektar Therapeutics · Healthcare
SVP and General Counsel Mark Andrew Wilson sold $86K of Nektar Therapeutics
Sold$86,382
$13.16Price
6,564Shares
−7%Stake
What NKTR did after the filing
- The stock from Wed, Nov 17 close, $192.75
- +5.1%
- S&P 500, same days
- +1.8%
Measured over 30 trading days, to the Dec 31 close.
Traded Tue, Nov 16. Filed Wed, Nov 17, 1:09 PM ET, during the session. Returns use the Nov 17 close and the Dec 31 close. Not investment advice.